CCL

Összesen 6 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM042514
035-os BibID:PMID:5130287
Első szerző:Árvay Sándor (szülész-nőgyógyász)
Cím:The effect of intensive nervous stimulation on certain physico-chemical properties of rat tail tendon and uterus collagen / A. Árvay, I. Takács, P. Ladányi, Á. Balogh, K. Benkő
Dátum:1971
ISSN:0004-3591
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
rat tendon
rat uterus
collagen
isometric tension
labile hypro
Megjelenés:Gerontologia. - 17 : 3 (1971), p. 157-169. -
További szerzők:Takács István (1928-1984) (szülész-nőgyógyász) Ladányi P. Balogh Ádám (1940-) (szülész-nőgyógyász, endokrinológus szakorvos) Benkő Kálmán
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM042513
035-os BibID:PMID:5494628
Első szerző:Balogh Ádám (szülész-nőgyógyász, endokrinológus szakorvos)
Cím:Electron microscopic studies of the adenohypophyses of aged rats / Á. Balogh, I Takács, P. Ladányi, A. Árvay
Dátum:1970
ISSN:0004-3591
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:Gerontologia. - 16 : 5 (1970), p. 313-323. -
További szerzők:Takács István (szülész-nőgyógyász) Ladányi P. Árvay Sándor (1903-1997) (szülész-nőgyógyász)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM042512
035-os BibID:PMID:9138964
Első szerző:Balogh Ádám (szülész-nőgyógyász, endokrinológus szakorvos)
Cím:Hormone replacement therapy and prevention of osteoporosis: risk assessment and practical advice / Adam Balogh, Peter Bettembuk
Dátum:1997
ISSN:0004-3591
Megjegyzések:A review of the Debrecen Regional Osteoporosis Program (DROP) in Hungary is given, with special reference to the detection of postmenopausal osteoporosis (PMOP) and its treatment by hormone replacement therapy (HRT). The new definition of osteoporosis by focusing on bone mineral density (BMD) measurements has the major advantage of practical usefulness. The algorithm of managing osteoporotic patients can be easily constructed from the result of bone densitometry as the primary diagnostic tool. The DROP serves a total population of 550,000, is equipped with a DXA bone densitometer, a bone metabolism laboratory and backed by a multidisciplinary team of clinicians from gynecology, radiology, rheumatology, internal medicine, and orthopedic surgery. In 1995 the total number of patients undergoing densitometry was 3170. In 2045 patients T scores of -1 or below were found. From this total number, 348 patients received HRT for 1 year or longer. The results of the treatment showed a positive response (i.e. no bone loss, or net gain) in 65%, while half of the 'non responders' proved in fact non compliant. The contradiction between risk assessment and early diagnosis is explained and replacing 'risk assessment' by 'selection criteria for bone densitometry' is proposed. 'Prevention of osteoporosis' is also to be replaced by 'prevention of complications', i.e. osteoporotic fractures. One of these measures is HRT. Its rational use in the prevention and treatment of osteoporosis and its relation to other treatment methods in the authors' own experience is discussed.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
külföldön készült közlemény
Megjelenés:European journal of obstetrics, gynecology, and reproductive biology. - 71 : 2 (1997), p. 189-191. -
További szerzők:Bettembuk Péter
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM042516
035-os BibID:PMID:2903093
Első szerző:Borsos Antal (szülész-nőgyógyász, gyermeknőgyógyász)
Cím:Ovarian function after the menarche and hormonal contraception / A. Borsos, L. Lampé, A. Balogh, J. Csoknyay, F. Ditrói, P. Székely
Dátum:1988
ISSN:0004-3591
Megjegyzések:The aim of the study was to determine the date of regular ovulation after the menarche to better understand the physiology of female adolescence, especially as it pertains to the use of hormonal contraception. Early morning urine samples were collected from 51 girls in the perimenarche for 9 weeks semi-annually during 2 years. Estrone- and pregnanediol-3-glucuronide values were determined. Cycles lasting 35-40 days at the onset of menses shortened to 28 days after the 23rd-25th cycle. Menses reached a 5.0-5.5 day average length at about the same time. After the 20th cycle, ovulation could be demonstrated in more than 50% of the study patients. Using a scoring system, regular ovulation could be expected on the basis of somatic data with scores of greater than 16. Hormonal contraception may be prescribed 2 years after the menarche, based on scores of greater than 16 and ovulation proven be hormonal cytology and basal body temperature.PIP:The increasing number of pregnancies among young teenagers has drawn attention to the timing of the onset of ovulation after menarche. As part of a broader study of menstrual and ovulatory patterns at puberty, estrone and pregnanediol-3-glucuronide levels were analyzed in urine samples collected from 51 girls in the perimenarche for 9 weeks semiannually over a 2-year period. Data pertaining to changes in the menstrual cycles of these 51 girls were analyzed in the course of 30 cycles and study participants kept menstrual calendars. Cycles lasting 35-40 days at the onset of menses shortened to 28 days after the 23rd-25th cycle. Menses reached a 5.0-5.5-day average length at about the same time. The frequency of ovulatory cycles was 10-13% after the 1st 7-10 menstrual cycles; it approached 50% after the 20th cycle. The pattern of normalization of menstrual cycles in young girls is important to defining the earliest date for the need of hormonal contraception without undue risk in order to prevent early pregnancy. The findings of this study suggest that hormonal contraception can be started 2 years after the onset of menses. However, attention should also be given to somatic development. The authors have developed a scoring system which considers the state of the breasts, pubic and axillary hair, and the uterus, as well as the results of hormonal cytological analysis and basal body temperature to more accurately detect the onset of regular ovulation.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:International Journal of Gynaecology and Obstetrics. - 27 : 2 (1988), p. 249-253. -
További szerzők:Lampé László (1929-2021) (szülész-nőgyógyász) Balogh Ádám (1940-) (szülész-nőgyógyász, endokrinológus szakorvos) Csoknyay Judit Ditrói Ferenc Székely Péter Balogh Ádám (1940-) (szülész-nőgyógyász, endokrinológus szakorvos)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM042517
035-os BibID:PMID:2880764
Első szerző:Borsos Antal (szülész-nőgyógyász, gyermeknőgyógyász)
Cím:Ovarian function immediately after the menarche / A. Borsos, L. G. Lampé, A. Balogh, J. Csoknyay, F. Ditroi
Dátum:1986
ISSN:0004-3591
Megjegyzések:Estrone and pregnanediol-glucuronide values of early morning urine samples collected from young girls in the perimenarche were determined by radioimmunological technique. A total of 58 teenage girls started collecting urine samples after their menarche at various times. Of these, 9 completed collection within 100 days of the onset of the first menstrual period. In 3 cases, insignificant changes in estrone and pregnanediol levels were noted. Normal estrone values were found in 3 cases together with pregnanediol levels suggestive of ovulation. In 2 further cases the possibility of ovulation without follicular release was suggested. The results indicate that ovarian activity is unpredictable immediately following the menarche. Between very low levels of sexual steroid hormone production and those normally observed in adult females, all transitional values could be found.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:International Journal of Gynaecology and Obstetrics. - 24 : 3 (1986), p. 239-242. -
További szerzők:Lampé László (1929-2021) (szülész-nőgyógyász) Balogh Ádám (1940-) (szülész-nőgyógyász, endokrinológus szakorvos) Csoknyay Judit Ditrói Ferenc
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM005618
Első szerző:Reginster, Jean-Yves
Cím:Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis / Jean-Yves Reginster, Dieter Felsenberg, Steven Boonen, Adolfo Diez-Perez, Rene Rizzoli, Maria-Luisa Brandi, Tim D. Spector, Kim Brixen, Stefan Goemaere, Catherine Cormier, Adam Balogh, Pierre D. Delmas, Pierre J. Meunier
Dátum:2008
Megjegyzések:This study was undertaken to assess the effect of strontium ranelate on nonvertebral and vertebral fractures in postmenopausal women with osteoporosis in a 5-year, double-blind, placebo-controlled trial. METHODS: A total of 5,091 postmenopausal women with osteoporosis were randomized to receive either strontium ranelate at 2 gm/day or placebo for 5 years. The main efficacy criterion was the incidence of nonvertebral fractures. In addition, incidence of hip fractures was assessed, by post hoc analysis, in the subset of 1,128 patients who were at high risk of fractures (age 74 years or older with lumbar spine and femoral neck bone mineral density T scores -2.4 or less). The incidence of new vertebral fractures was assessed, using the semiquantitative method described by Genant, in the 3,646 patients in whom spinal radiography (a nonmandatory procedure) was performed during the course of the study. Fracture data were analyzed using the Kaplan-Meier survival method. RESULTS: Of the 5,091 patients, 2,714 (53%) completed the study up to 5 years. The risk of nonvertebral fracture was reduced by 15% in the strontium ranelate group compared with the placebo group (relative risk 0.85 [95% confidence interval 0.73-0.99]). The risk of hip fracture was decreased by 43% (relative risk 0.57 [95% confidence interval 0.33-0.97]), and the risk of vertebral fracture was decreased by 24% (relative risk 0.76 [95% CI 0.65-0.88]) in the strontium ranelate group. After 5 years, the safety profile of strontium ranelate remained unchanged compared with the 3-year findings. CONCLUSION: Our findings indicate that treatment of postmenopausal osteoporosis with strontium ranelate results in a sustained reduction in the incidence of osteoporotic nonvertebral fractures, including hip fractures, and vertebral fractures over 5 years.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Arthritis and Rheumatism 58 : 6 (2008), p. 1687-1695. -
További szerzők:Felsenberg, Dieter Boonen, Steven Diez-Perez, Adolfo Rizzoli, Rene Brandi, Maria-Luisa Spector, Tim D. Brixen, Kim Goemaere, Stefan Cormier, Catherine Balogh Ádám (1940-) (szülész-nőgyógyász, endokrinológus szakorvos) Delmas, Pierre D. Meunier, Pierre J.
Internet cím:DOI
elektronikus változat
Borító:
Rekordok letöltése1 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.